期刊文献+

1142例胃癌切除术围手术期死亡因素分析 被引量:35

Postoperative mortality after gastrectomy for gastric cancer: analysis of 1142 cases
原文传递
导出
摘要 目的研究影响胃癌围手术期死亡的主要因素,为指导选择合理的切除范围和手术方式提供依据。方法回顾1989年1月至2004年3月胃癌手术后1142例患者的临床资料,按照不同年代分为3组,第1组:1989年1月至1994年1月,405例;第2组:1994年2月至1999年1月,377例;第3组:1999年2月至2004年3月,360例。比较3组间的围手术期死亡率,采用Logistic多因素回归分析研究影响手术死亡率的危险因素。结果全组患者术后并发症发生率和死亡率分别为11.2%(128/1142)和3.6%(41/1142)。第1、2、3组的术后并发症发生率依次为13.1%、10.1%和10.3%;3组比较,P>0.05。3组手术死亡率依次为4.7%、3.4%和2.5%,3组比较,P>0.05。术后最常见的并发症是吻合口瘘(24.2%,31/128),影响手术死亡的主要因素为临床Ⅳ期、姑息性切除术、联合脏器切除及术前合并症的存在(P<0.05)。Logistic多元回归分析显示淋巴结的清除范围和手术方式不是影响手术死亡的主要因素(P>0.05)。结论胃癌晚期患者手术死亡率高,对胃癌Ⅳ期患者行姑息性切除手术时应避免施行不必要的淋巴结清除及联合脏器切除术。 Objective To analyze postoperative morbidity and mortality after gastreetomy for gastric carcinoma and identify main risk factors influencing mortality. Methods A total of 1142 patients with gastric cancer received gastrectomy between January 1989 and April 2004. The patients were divided into three groups according to different period, the first group ( n =405): from January 1989 to January 1994; the second group ( n = 377): from February 1994 to January 1999; the third group ( n = 360): from February 1999 to March 2004. Postoperative morbidity and mortality were compared among three groups, the risk factors influencing postoperative mortality were determined by multiple logistic regression analysis. Results The total postoperative morbidity and mortality for all patients were 11.2% (128/1142) and 3.6% (41/1142), respectively. The postoperative morbidity was 13. 1%, 10. 1%, and 10.3% in the first, second, and third group respectively, there was no significant difference in morbidity among the three groups (P 〉 0.05). The postoperative mortality was 4. 7%, 3.4%, and 2.5% respectively( P 〉 0.05), there was no significant difference in mortality among the three groups( P 〉 0.05 ) . The most common postoperative complication was anastomotic leakage(24.2%, 31/128). The following clinicopathologic factors were found to be correlated with postoperative mortality: stage Ⅳ ; palliative excision; muhivisceral resection; and preoperative complications(P 〈 0. 05) . Multivariate analysis revealed that the extent of lymph node dissection or surgical procedure were not main risk factors influencing mortality. Conclusions Patients with advanced gastric cancer have a high risk of postoperative mortality. Unnecessary lymph node dissection or muhivisceral resection should be avoided for patients with stage Ⅳ gastric cancer.
出处 《中华胃肠外科杂志》 CAS 2005年第5期422-424,共3页 Chinese Journal of Gastrointestinal Surgery
  • 相关文献

参考文献8

  • 1Hanson LE,Ekstrom AM, Bergstrom R,et al. Surgery for stomach cancer in a defined Swedish population: current practices and operative results. Eur J Surg, 2000,166:787-795.
  • 2Keguchi M,Oka S,Gomyo Y,et al. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma. Hepato-gastroenterology, 2001,48:1517-1520.
  • 3Gunther K,Horbach T,Merkel S,et al. D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications. Surg Today,2000,30:700-705.
  • 4Edwards P, Blackshaw GRJC, Leiwis WG, et al. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer,2004,90: 1888-1892.
  • 5Degiuli M,Sasako M,Calgaro M,et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer:interim analysis of the Italian gastric cancer study group (IGCSG) randomized surgical trial. Eur J Surg Oncol,2004,30:303-308.
  • 6张建中,卢辉山,黄昌明,吴心愿,官国先,王川,郑朝晖,张祥福.615例胃癌行全胃切除术的远期疗效[J].中华胃肠外科杂志,2002,5(1):13-16. 被引量:27
  • 7詹友庆,李威,孙晓卫,仲坚,徐立.胃癌的外科治疗[J].中华胃肠外科杂志,2002,5(1):28-31. 被引量:15
  • 8Ichikawa D,Kurioka H,Yamaguchi T,et al. Postoperative complications following gastrectomy for gastric cancer during the last decade. Hepatogastroenterology,2004,51:613-617.

二级参考文献21

  • 1金庆文,张熙曾,卫刚,王广舜,李洪贵.贲门癌的全胃切除治疗[J].中国肿瘤临床,1994,21(2):104-107. 被引量:9
  • 2张大为 程贵余 等.贲门腺癌的外科治疗经验(937例总结)[J].中华肿瘤杂志,1988,10(5):376-376.
  • 3陈峻青 齐春莲 单吉贤 等.胃癌浆膜的分型及其意义[J].中华医学杂志,1986,66:736-736.
  • 4徐光炜 吴阶平 裘法祖 主编.胃癌[A].吴阶平,裘法祖,主编.黄家驷外科学:第6版[C].北京:人民卫生出版社,2000.1046-1049.
  • 5徐光炜.胃癌.见张天泽,徐光炜主编.肿瘤学(中册)[M].第1版.北京:人民卫生出版社,1993:1477.
  • 6近滕远平.胃全摘术式の历史[J].临外,1990,52:263-266.
  • 7Wilke H,Preusser P,Fink U,et al.Preoperative chemotherapy in locally advanced and nonresectable gastric cancer:a phase Ⅱ study with etoposide,doxorubicin,and cisplatin.J Clin Oncol,1989,7:1318-1326.
  • 8Fujimura T,Yonemura Y,Muraoka K,et al.Continuous hyperthermic perthrmic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer.Randomized controlled study.World J Surg,1994,18:150 155.
  • 9Nakazato H,Koike A,Saji S,et al.Efficacy of immunoche motherapy as adjuvant treatment after curative resection of gastric cancer.Lancet,1994,343:1122-1126.
  • 10Tanaka Y,Migita T,Sakamoto H,et al.Standard surgical treatment of gastric cancer.Nippon Rinsho.2001,59:331-336.

共引文献36

同被引文献268

引证文献35

二级引证文献227

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部